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Introduction 
INTRODUCTION
Skin and soft tissue infection (SSTIs) are common type of infection that 
may  contribute  to  longer  hospital  stays,  significantly  increase  the  cost  of 
medical care, and are likely to have an important role in the development of 
antimicrobial resistance.65 Most of these infections are superficial and readily 
treated  with  a  regimen  of  local  care  and  antibiotics.  However,  soft  tissue 
infections involving deeper layers like fascia and muscle can rapidly progress 
to systemic sepsis and prove fatal.95 Staphylococcus aureus is one of the 
common organisms associated with soft tissue infection.88
S.  aureus are  ubiquitous  organisms  and  among  the  most 
commonly  encountered  in  medical  practice.  S.  aureus has  been 
reported  as  a  major  cause  of  community  and  hospital  acquired 
infections.93 The  organisms  has  a  differential  ability  to  spread  and 
cause outbreaks in hospitals.113 Infections caused by S. aureus used to 
respond  to  β-lactam  group  of  antibiotics.  Penicillin  –  resistant  S. 
aureus strains began emerging shortly after introduction of penicillin in 
1940.Resistance  to  methicillin  and  other  β-lactamase  –  resistant 
Penicillin  was  first  observed  in  S.aureus soon  after  methicillin  was 
introduced into clinical use in 1961.92
methicillin  resistant  Staphylococcus  aureus (MRSA)  are 
significant  pathogen  that  have  emerged  over  the  past  30  years  to 
cause both nosocomial and community acquired infections. There has 
been  a  steady  increase  in  the  prevalence  of  MRSA  isolated  in 
hospitals.  Indian literature shows that MRSA incidence was as low as 
20% in 2002 (Supriya et al 2002) and reached to 43% in 2008 (Erics et 
al 2008)
The prolonged hospital stay, indiscriminate use of antibiotics and 
the  lack  of  awareness  are  possible  predisposing  factors  for  MRSA 
emergence.5 Serious  endemic  and  epidemic  MRSA  infections  occur 
globally  as  infected  and  colonized  patients  in  hospitals  mediate  the 
dissemination  of  these  isolates  and  hospital  staff  assists  further 
transmission.1
Many  of  the  MRSA  strains  are  multidrug  resistant  and  are 
susceptible  only  to  glycopeptides  antibiotics  such  as  vancomycin.84 
Therefore  the  knowledge  of  prevalence  of  MRSA  and  their  current 
antimicrobial profile becomes necessary in the selection of appropriate 
empirical treatment of these infections.
Expression  of  methicillin  resistance  in  clinical  laboratories  is 
subject  to  environmental  conditions  like  pH,  incubation  time, 
temperature  and  salt  concentration  of  the  medium85.  Conditional 
expression  of  PBP2a may cause  ambiguity  in  susceptibility  tests.  To 
complicate  matters  further,  methicillin  resistance  is  often  expressed 
heterogeneously  in  that  only  108 cells  of  the  population  are 
phenotypically resistant. These factors emphasize the need to develop 
a  rapid,  standard,  accurate  and  sensitive  method  for  detection  of 
methicillin resistance in Staphylococcus aureus which is not dependent 
on growth conditions39.
The  conventional  methods  to  detect  MRSA  in  the  laboratory 
include  oxacillin  disc  diffusion,  cefoxitin  disc  diffusion,  MIC 
determination  by  agar  or  broth  dilution  method  and  oxacillin  screen 
agar method. Numerous approaches that improve the turn around time 
for the detection of MRSA have been described. PCR is considered the 
gold  standard;  it  is  rapid  with  a  high  degree  of  sensitivity  and 
specificity12.
    
The  sooner  an  MRSA  infection  is  diagnosed  and  the 
susceptibility  to  antimicrobial  agents  established,  the  earlier 
appropriate  therapy  and  control  measures  can  be  initiated. 
Identification  and  antimicrobial  susceptibility  testing  are  therefore 
crucial steps in treating, controlling and preventing MRSA infection.
Hence  this  study  has  been  undertaken  to  compare  the 
conventional  methods of  detecting MRSA infection with  the molecular 
technology  and  also  to  determine  the  antimicrobial  susceptibility 
pattern  of  MRSA in  a  tertiary  care  hospital  which  will  facilitate  in  the 
implementation of appropriate treatment of the patients.
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REVIEW OF LITERATURE 
HISTORICAL PERSPECTIVE  
 In  1884,  Rosenbach  provided  the  first  formal  description  the 
genus  Staphylococcus and  divided  the  genus  into  two  species 
Staphylococcus  aureus and  Staphylococcus  albus.  In  1885,  Passet 
added a third species Staphylococcus citreus.92
In 1989, the genus Staphylococcus was brought under the broad 
Bacillus –  Lactobacillus –  Streptococcus cluster  consisting of  Gram – 
positive bacteria that have a low G + C Content of DNA.14
The closest relatives of Staphylococci are the Macrococci and on 
the basis of partial oligonucleotide sequencing,  Staphylococci are also 
related to Salinococci, Enterococci, Planococci, Bacillus and Listeria.92
DEFINITION OF GENUS 
Members of  the genus  Staphylococcus are Gram positive  cocci 
measuring  0.5  –  1.5  µm,  that  occurs  singly,  in  pairs  in  tetrads,  short 
chains  and  irregular  grape  like  clusters.  They  are  non  –  motile,  non 
spore forming, catalase positive,  facultatively anaerobic and are often 
unencapsulated. 31
Staphylococcus are susceptible to furazolidone (100µg) and are 
resistant to low levels of bacitracin (0.04 units). They are susceptible to 
lysis by lysostaphin and are relatively resistant to lysis by lysozyme.92
Staphylococcus is currently composed of 37 species, 16 of which 
are found in humans. The most virulent ones include S. aureus and S. 
lugudensis in humans and S. aureus and S. intermedius in animals.103
HABITAT
   S.  aureus are  ubiquitous  colonizers  of  the  skin  and  mucosa  of 
virtually  all  animals,  including  mammals  and  birds.73 S.  aureus 
demonstrates a preference for the anterior nares especially in adults.80 
It can exist as a resident or as a transient member of the normal flora. 
Nasal carrier rate may vary from 10% - 40% in both the community and 
the  hospital  environment.110 Nasal  carriage  of  S.  aureus has  also 
become  a  means  of  persistence  and  spread  of  multiresistant 
Staphylococcus especially MRSA.108
CELL MORPHOLOGY AND CULTURAL CHARACTERISTICS :
LIGHT MICROSCOPY 
Gram  stained  cells  of  Staphylococcus are  uniformly  Gram 
positive  in  young  cultures  and  appear  spherical  with  an  average 
diameter  of  0.5  –  1.5µm.92 Cell  wall  defective  or  deficient  (L  –  form) 
cells have been described for S. aureus.  54
CULTURAL CHARACTERISTICS
 Colonies of most Staphylococcus species grow rapidly and are 1-3 
mm in diameter after 24 hours of incubation. Staphylococcal colonies are 
usually  smooth,butyrous  and  have  a  low  convex  profile  with  a  entire 
edge.  Pigmentation  is  characteristic  of  this  species  when  grown 
aerobically and ranges from cream through buff to gold. Pigmentation is 
enhanced on fatty media such as Tween agar,  by prolonged incubation 
and  by  leaving  plates  at  room  temperature  .Staphylococcus  aureus is 
tolerant  of  concentrations  of  sodium chloride  that  inhibit  other  bacteria 
and  on  Mannitol  salt  agar  it  forms  1mm  diameter  yellow   colonies 
surrounded by yellow medium due to acid formation. On MacConkey or 
Cysteine  Lactose  Electrolyte  Deficient  agar  (CLED)   it  acquires  the 
appropriate  colour  of  the  indicator,depending  on  whether  or  not  the 
particular strain ferments lactose.8,31 
Several  selective  media  have  been  devised  for  isolating  S. 
aureus.  These  include  mannitol  salt  agar.  Salt  milk  agar,  salt  broth, 
lipase  –  salt  –  mannitol  agar,  phenyl  ethyl  alcohol  agar,  Columbia 
Colistin Nalidixic acid (CNA) agar, Baird –Parker agar base.92
Severe unusual morphotypes of  S. aureus have been described 
that depart significantly from the normal colony morphology and include 
certain  encapsulated  strains112,  L  –  forms54 and  small  colony  variant 
(SCV)92.  SCV’s are believed to have a defect in the electron transport 
and  are  resistant  to  aminoglycosides.115 They  are  most  commonly 
isolated  from  persistent  infections  such  as  cystic  fibrosis  or  chronic 
osteomyelitis.63
BIOCHEMICAL REACTIONS
Staphylococcus aureus are:
   Catalase positive 
Hydrolyse urea
Reduce nitrates to nitrites
Liquefy gelatin
Methyl Red and Voges Prosakeur test positive
Indole test – negative
Produce phosphatase
Hydrolyse DNA
Slide coagulase and Tube coagulase test positive 
Reduce  Tellurite  to  form  black  colonies  in  Potassium  tellurite 
medium
Produce themostable nucleases
They  ferment  a  number  of  sugars  producing  acid  but  no  gas. 
Sugar fermentation is of no diagnostic value except for mannitol, which 
is usually fermented by S. aureus but not by other species.31,92,8
PATHOGENESIS OF S. AUREUS INFECTIONS
S.  aureus expresses  many  cell  surface  associated  and  extra 
cellular proteins that are potential virulence factors92.
a) Adherence protein
S.  aureus expresses  on  their  surface  the  following  protein  that 
promote attachment to host proteins77.
1) Fibronectin binding protein A & B
2) Clumping factor A & B
3) Collagen binding protein 
4) Bone sialoprotien binding protein
5) Elastin binding protein
6) Plasmin sensitive protein
7) Biofilm associated protein
b) Avoidance of host defense :
i) Capsular polysaccharide – serotype 5 or 8 
It  is  also  called  as  Microcapsule  because  it  can  be  visualized 
only by Electron microscopy after antibody labelling.
2) Protein A  
It is a surface protein of S.aureus which binds to the Fc region of 
Ig-G  and disrupts opsonization and phagocytosis102
c) Damage to hosts92 ;
I  Membrane damaging toxins :
1) α - toxin – cytolytic pore forming toxin
2) β – toxin – neural sphingomyelinase
3) δ - toxin - surfactant on various cells
4) γ - toxin –Bicomponent toxin
Cytolytic for erythrocytes and leukocytes
5) Panton Valentine Leukocidin – cytolytic for leukocytes  
II Pyrogenic toxin –Superantigens
1) Enterotoxins – Ingestion of performed toxin in food results in 
nausea, vomiting and diarrhoea
2) TSST – 1 – Toxic Shock Syndrome Toxin
3)  Exfoliative  toxin  A  &  B  –  Staphylococcal  scalded  skin 
syndrome 
III) Enzymes92 :
i) Fibrin forming and fibrinolytic enzymes
a) Staphylocoagulase  :  -   It  reacts  with  coagulase 
reacting  factor  in  the  plasma  and  the  resulting 
complex,  Staphylothrombin  converts  fibrinogen  to 
fibrin.
b) Staphylokinase – Binds to plasminogen and activates it to 
become the fibrinolytic enzyme plasmin. 
ii) Bacteriolytic enzyme 
Endo – β – N – acetyl glucosaminidase
Lysotaphin endopeptidase
iii) Hydrolytic enzymes
Lipase
Thermonuclease
Urease
Hyaluronidase
Protease
CLINICAL SYNDROMES 
 In general, infection begin with the colonization of target tissues 
by the microbes. S. aureus mainly colonizes the anterior nares. Further 
infection  results  from more  specific  invasion  processes,  during  which 
bacteria interacts directly or indirectly (through toxins) with the host80.
S.  aureus causes  a  wide  range  of  infections.  These  can  be 
broadly divided into community and hospital acquired  infections92.
Community acquired infection include the following :
1) Toxin-mediated disease61 :- Staphylococcal scalded skin syndromes 
Toxic  shock syndrome 
Staphylococcal food poisoning 
2) Skin and soft tissue infections92 :
The basic pathologic lesion induced by  S. aureus is  a pyogenic 
exudate or an abscess. S. aureus infection of skin and soft tissues are 
classified according to the anatomic structure involved :-
Impetigo 
Folliculitis 
Furuncles, carbuncles Erysipelas, cellulitis, fascitis 
3) Bone and joint sepsis;
S.  aureus is  the  leading  cause  of  primary  septic  arthritis  and 
osteomyelitis7.
4) Bacteremia and endocarditis :
Around  two  –  third  of  patients  with  S.  aureus bacteremia  are 
nosocomially  acquired  most  of  which  are  associated with  intravenous 
device related infection. Infective endocarditis on a native valve is one 
of the most severe complications of S. aureus bacteremia35.
II. Nosocomial or Hospital acquired infection43; 
Surgical wound infection
Ventilator associated pneumonia.
Bacteremia associated with intravenous devices
Infection  associated  with  prosthetic  material  such  as  CSF 
shunts, prosthetic joints and vascular grafts.
GENE REGULATION
S.  aureus gene  expression  is  under  the  control  of  regulatory 
systems that respond to change in environmental conditions. The best 
characteristics of the regulatory systems are the Agr (Accessory global 
regulator) and Sar (Staphylococcal accessory regulator)75.
PLASMIDS 
Plasmids  are  facultative  extrachromosomal  genetic  elements 
which  are  common  in  natural  population  of  most  Staphylococcal 
species111.  S. aureus plasmids have been classified into three genera 
classes I,II and  III . Class I plasmid usually encodes a single antibiotic 
resistance74.  Class II  plasmid is  commonly referred to  as penicillnase 
or  β  –  lactamase  plasmids94.  Class  III  plasmid  encode  resistance  to 
gentamicin, tobramycin and kanamycin41.
BACTERIOPHAGES 
Typing of  S. aureus strains by an official  International basic set 
of  phages  found  wide  use  as  an  established  method  for 
epidemiology114. Human strains of S. aureus belong to phage groups I, 
II,  III  or V107.  Phage typing was the mainstay of typing for many years 
but  has  been  replaced  by  Ribotyping,  Pulse  field  gel 
electrophoresis(PFGE),  Multilocus  enzyme  electrophoresis  (MLEE), 
Plasmid profiling and Multilocus sequence typing (MLST)92.
RESISTANCE TO ANTIMICROBIAL AGENTS
  The rising level of resistance to a wide range of antibiotics by S. 
aureus represent  a  significant  threat  to  future  treatment 
efficacy92.Since  the  beginning  of  the  antibiotic  era,  S.  aureus has 
responded  to  the  introduction  of  new  drugs  by  rapidly  acquiring 
resistance by a variety of genetic mechanisms including64.
1) Acquisition  of  extrachromosomal  plasmids  or  additional  genetic 
information in the chromosome via transposons or other types of 
DNA insertion.  
2) By mutations in chromosomal genes
RESISTANCE OF STAPHYLOCOCCI TO Β-LACTAM ANTIBIOTICS:
  Penicillin  resistant  S.  aureus strains  began  emerging  shortly 
after the introduction of penicillin in medicine in the early 1940’s. Today 
the percentage of penicillin – resistant strains has risen to 75-95% with 
the  highest  rates  being  found  among  the  hospital  strains92.  Most 
penicillin  resistant  Staphylococcal strains  produce  β-lactamase  which 
hydrolyses  the  β-lactam  ring  of  the  antibiotic  rendering  the  β-lactam 
inactive.  β-lactamase  genes  (blaz)  are  most  often  found  on  class  II 
plasmids.  Blaz  gene  is  under  the  control  of  two  adjacent  regulatory 
genes, the antirepressor bla R1 and the repressor blaI 55.
METHICILLIN RESISTANCE 
a) HISTORY AND EPIDEMIOLOGY
Resistance  to  Methicillin  and  other  β-lactamase  resistant 
Penicillins  was  first  observed  in  S.  aureus soon  after  methicillin  was 
introduced into clinical use in Britain52. The methicillin resistant strains 
isolated in  Britain  at  that  time came from hospitalized patients,  which 
were multiple antibiotic resistant, belonged to phage group III and their 
resistance to methicillin was heterogenous affecting only a minority of 
the cell population9.
After the mid 1970’s large outbreaks of infection by MRSA were 
recorded in many hospitals92. Many of these outbreaks appear to have 
been caused by a single epidemic strain that was transferred between 
hospitals  by  the  movement  of  patients28.  A  nomenclature  has  been 
developed to differentiate strains associated with epidemic MRSA from 
those associated with sporadic infections which do not appear to have 
the  same  degree  of  transmissibility.  MRSA  is  now  responsible  for 
around 30% of more of all serious S. aureus infections92.
The Indian scenario
One  of  the  earliest  reports  from  India  was  1982,  where  an 
incidence of 26.6% was reported by Bhatia et al10.  In 1996, Pullimood 
et  al.,  from  Vellore  reported  an  MRSA  isolation  rate  of  24%78.  The 
following  a  Mabel  from  Thiruvananthapuram  reported  an  MRSA 
isolation  rate  of  16.4%9,  while  Udhaya  Shankar  et  al.,  reported  the 
figure as 20% from Pondicherry106. 
A  systematic  study  done  in  Delhi  over  six  months  period  by 
Krishna  Prakash  et  al  in  2001  reported  an  MRSA  isolation  rate  of 
38.6%59.  In 2003,  Hanumanthappa et al.,  reported an isolation rate  of 
43%46. A higher rate of 54.85% has been reported in the same year by 
Anupurba S et al., from Banaras1. 
The therapeutic outcome of infections that  result  from MRSA is 
worse  than the outcome of  those that  result  from methicillin  sensitive 
strains.  The  difference  has  been  ascribed  to  the  underlying  medical 
problem  as  well  as  the  less  effective  bactericidal  drugs  available  to 
treat these infections, rather than to enhanced virulence of the MRSA 
strains52. Like the penicillin – resistant strains, the MRSA isolates also 
frequently carry resistance genes to other antimicrobial agents36.
MECHANISM OF RESISTANCE 
    Methicillin  resistance  requires  the  presence  of  the 
chromosomally localized mec A gene55.The  mec A gene is responsible 
for  the synthesis  of  penicillin  binding protein  2a (PBP2a :  also called 
PBP2)  –  a  78  KDa  protein19.  Pencillin  binding  proteins  (PBPs)  are 
membrane bound enzymes that catalyzes the transpeptidation reaction 
that is necessary for cross – linkage of peptidoglycan chains55. PBP2a 
substitutes for the other PBPs and because of its low affinity for all β-
lactam antibiotics,  enables  Staphylococci to  survive  exposure  to  high 
concentration  of  these  agents.  Thus,  resistance to  methicillin  confers 
resistance to all  β-lactam antibiotics including cephalosporins . PBP2a 
differs  from other  PBPs in  that  its  active  site  blocks  binding  of  all  β-
lactams but allows the transpeptidation reaction to proceed36.
The mec A is part of a genomic island designated Staphylococcal 
Cassette  Chromosome mec (SCC mec)56.  To date,  four different SCC 
mec elements  have  been characterized50.  The recent  upsurge of  CA- 
MRSA  infections  reported  in  patients  from  different  countries  was 
associated  with  the  detection  of  a  unique  SCC  mec,type  IV.  This 
element,  smaller  than  the  other  elements,  appears  more  genetically 
mobile and does not carry additional antimicrobial resistance genes26.
Phenotypic  expression  of  methicillin  resistance  is  variable105. 
Expression in the MRSA strain is regulated by genes mecI and mecRI. 
An  additional  series  of  genes,  the  fem  genes  (factors  essential  for 
methicillin resistance), play a role in crosslinking peptidoglycan strands 
and  also  contribute  to  the  heterogeneous  expression  of  methicillin 
resistance2.
Since  no  homologue  of  mec  A exists  in  methicillin  susceptible 
Staphylococcus aureus, it has been assumed that mec A was acquired 
from  one  of  several  Coagulase  negative  Staphylococcal  species50.  A 
mec  A homolog  with  88% amino  acid  similarity  to  mec  A MRSA has 
been identified in S. sciuri24.
QUINOLONE RESISTANCE 
 Fluoroquinolones were initially introduced for the treatment of 
Gram negative bacterial infection in 1980. However, because of their 
Gram positive bacterial spectrum, they have also been used to treat
 bacterial infections caused by Staphylococci. Quinolone resistance
 among S. aureus emerged quickly, more prominently among the 
methicillin – resistant strains36.
Three  mechanisms  of  fluroquinolones  resistance  have  been 
postulated for Staphylococci
1) Mutations in chromosomal gene gyr A, encoding the DNA gyrase, so 
that its function is no longer inhibited by the antibiotic97.
2) Mutations  in  chromosomal  gene  norA that  encodes  a  membrane 
efflux protein for hydrophilic fluoroquinolone117.
3) Mutations  in  chromosomal  gene  grl  A that  encodes  the  DNA 
topoisomerase IV34
When  quinolones  are  used  to  treat  infections  caused  by  other 
bacterial  pathogens,  subjects  colonized  with  S.  aureus are  likely 
exposed to subtherapeutic antibiotic concentration and therefore at risk 
of  becoming  colonized  with  resistant  mutants47.  These  resident 
resistant strains then become the reservoir for future infection49.
RESISTANCE OF  S. AUREUS TO VANCOMYCIN:
 The glycopeptide antibiotics vancomycin and teicoplanin bind to 
the peptidyl  – D alanyl D alanine terminus of peptidoglycan precursors 
and  prevent  the  transglycosylation  steps  of  cell  wall  peptidoglycan 
synthesis. Since this mode of action is different from that of  β-lactams, 
glycopeptides  are  being  used  to  treat  severe  infections  caused  by 
methicillin and other β-lactam resistant Staphylococci92.
The  dramatic  increase  in  the  use  of  vancomycin  to  treat 
infections  caused  by  methicillin  resistant  Staphylococci  and 
Enterococcal  infections  preceeded  the  emergence  of  vancomycin 
resistant  Staphylococci.32 Staphylococci resistant  to  vancomycin  in  a 
clinical isolate was first reported in a strain of S. hemolyticus58.
 In 1997, the first report of vancomycin intermediate resistant S. 
aureus (VISA)  came  from  Japan29.  The  first  vancomycin  resistant  S. 
aureus (VRSA) was reported in Michigan in July 200217. In contrast to 
the chromosomally mediated resistance for VISA strains VRSA  acquire 
resistance by conjugal transfer of the Van A operon from Enterococcus 
faecalis47.
RESISTANCE TO MACROLIDE, LINCOSAMIDE AND 
STREPTOGRAMIN : - (MLS)
Methicillin resistant Staphylococci often have cross resistance to 
Macrolides  (erythromycin,  spiramycin,  clarithiomycin,  azithriomycin), 
lincosamides  (lincomycin,  clindamycin)  and  streptogramin  type  B 
antibiotics – designated as MLS resistant.  The different  types of  MLS 
antibiotics  bind  to  the  50S  ribosomal  subunit  and  interfere  with 
transpeptidation  and translocation reactions needed for  peptide  chain 
elongation92.
RESISTANCE TO TETRACYCLINE
This  is  widespread  among  Staphylococcus species  and  ranks 
along with β-lactams and MLS resistance as one of the most frequent 
types  of  antibiotic  resistance91.  There  are  two  mechanisms  for 
tetracycline resistance found in Staphylococci.  The most common one 
involves an energy dependent pumping of tetracycline from the cell so 
that  levels  of  these  antibiotics  are  reduced  below  that  required  to 
inhibit  the  ribosome23.  The  second  mechanism  involves  ribosome 
protection  so  that  protein  synthesis  is  unaffected  by  the  presence  of 
tetracycline, doxycycline or minocycline90.
RESISTANCE TO AMINOGLYCOSIDES 
There  are  three  major  mechanisms  responsible  for 
aminoglycoside  resistance  in  S.  aureus .  One  mechanism  involves 
changes in ribosomal protein as a consequence of certain mutations in 
their  structural  genes  such  that  ribosomes  can  no  longer  bind 
streptomycin104.  A  second  mechanism  involves  energization  and 
permeability of cell membrane. The third and most common mechanism 
of  resistance  involves  modification  of  aminoglycosides  by 
aminoglycoside modifying enzymes so that the antibiotics are no longer 
capable of binding to ribosomes92.
RESISTANCE TO TRIMETHROPIM                                           
Trimethoprim  resistance  is  due  to  overproduction  of  the  native 
dihydrofolate  reductase  or  a  reduced  affinity  of  the  native  DHFR  for 
trimethoprim or a trimethoprim resistant DHFR92.
LABORATORY DIAGNOSIS 
  Direct microscopic examination of  normally sterile fluids – CSF, 
joint aspirates and pus aspirated from deep sites, may provide a rapid, 
presumptive report of Gram positive cocci resembling Staphylococci. 
Isolation  of  Staphylococci  from  primary  clinical  specimens  is 
usually  performed  using  blood  agar  –  eg.  Tryptic  soy  agar 
supplemented with 5% sheep blood, followed by incubating at 35-37oC 
for  18-24  hours.  Most  Staphylococcal species  will  produce  abundant 
growth and the colonies are usually 1-3 mm in diameter, golden yellow 
pigmented,  hemolytic,  circular,  smooth  and  raised  with  a  butyrous 
consistency92.  Screening  for  the  presence  of  S.  aureus in  mixed 
cultures  such  as  nasal  swabs  is  often  performed  using  mannitol  salt 
agar,  Columbia colisitin  –  nalidixic  acid agar,  lipase – salt  –  mannitol 
agar  or  phenyl  ethyl  alcohol  agar.  These  media  inhibit  the  growth  of 
Gram negative organisms but allow Staphylococci to grow92.
S.  aureus is  identified  by  its  colony  morphology.  Gram  stain 
demonstrates  the  presence  of  Gram  positive  cocci  in  clusters  and  it 
also  gives  a  positive  catalase  test8,92.  S.  aureus strains  are  usually 
identified by 
1) Slide and tube coagulase test
2) Mannitol fermentation
3) Gelatin liquefaction
4) Phosphatase production
5) DNA hydrolysis
6) Thermonuclease test
7) Latex agglutination test detecting the presence of protein A
MOLECULAR METHODS: 
 Most molecular methods for identification of S. aureus have been 
PCR based27.  A range of primers designed to amplify species specific 
targets have now been developed66. Such targets include the 
Nuclease (nuc)
Coagulase (Coa)
16s ribosomal RNA
Surface protein A (Spa)
Factors essential for methicillin resistance - fem A & fem B
DETECTION OF METHICILLIN RESISTANT S. aureus :
 In  assessing  the  performance  of  susceptibility  testing  method, 
the  Minimum  Inhibitory  Concentration  (MIC)  determination  by  the 
dilution  method  has  traditionally  been  the  reference  method.  MIC 
methods  have  now  been  replaced  as  the  reference  methods  by 
molecular  methods  which  detect  the  mec A  gene.  Disc  diffusion 
methods remains the most widely used in routine clinical laboratories27.
I) DISC DIFFUSION METHODS
 Standardized  methods  have  been  defined  by  the  Clinical 
Laboratory  Standards  (CLSI)25.  Oxacillin  disc  (1µg)  is  used  to 
determine methicillin resistance70. Cefoxitin disc (30 µg) diffusion tests 
are more reliable than those with Oxacillin27.
2) MIC DETERMINATION 
1) Agar dilution method
2) Broth -Micro dilution method
-Macro dilution method
3) E - test
Procedure
Serial  dilution  of  Oxacillin  is  added  onto  Mueller  Hinton  agar  / 
broth  with  2%  Nacl.  A  young  peptone  water  culture  of  S.  aureus 
corresponding to 0.5 McFarland turbidity is used as the inoculum and it 
is incubated at 33-35oC for 24 hours71.
Oxacillin MIC ≤ 2 µg/ml – susceptible
> 2 µg/ml – resistant
E – test method
E  –  test  also  known  as  the  epsilometer  test  is  an  exponential 
gradient  testing  methodology  where  E  in  E  test  refers  to  the  Greek 
symbol  Epsilon.  The  E  test  which  is  a  quantitative  method  for 
antimicrobial susceptibility testing applies both the dilution of antibiotic 
and  diffusion  of  antibiotic  into  the  medium.  A  predefined  stable 
antimicrobial gradient is present on a thin inert carrier strip. When this 
E  test  strip  is  applied  onto  an  inoculated  agar  plate,,there  is  an 
immediate  release  of  the  drug.  Following  incubation,a  symmetrical 
inhibition  ellipse  is  produced.  The  intersection  of  the  inhibitory  zone 
edge  and  the  calibrated  carrier  strip  indicates  the  MIC  value  over  a 
wide concentration range with inherent precision and accuracy62.
3) AGAR SCREENING METHOD 
This  method  recommends  the  use  of  Mueller  Hinton  agar  with 
4% Nacl  and 6µg/ml  of  oxacillin.  The test  organism corresponding  to 
0.5 Mc Farland turbidity standard is inoculated as a spot and the plates 
are  incubated  at  35oC for  24  hours.  Any  growth  on  the  agar  plate  is 
indicative of resistance69. 
4) LATEX AGGLUTINATION TESTS
 A  rapid  slide  latex  agglutination  test  based on the  detection  of 
PBP2a is  available.  This  methods  involves  extraction  of  PBP2a from 
suspensions  of  colonies  and  detection  by  agglutination  with  latex 
particles coated with monoclonal antibodies to PBP2a. This test is very 
sensitive  and  specific  with  S.  aureus but  may  not  be  reliable  for 
colonies grown on media containing Nacl13.
5) MOLECULAR METHODS
The earliest molecular methods for the detection of  mec A gene 
relied  on  either  radiolabelled  or  digoxigenin  (DIG)  labeled  DNA 
probes4.  More  recently  PCR  –  based  methods  have  been  used 
routinely  by  reference  laboratories  as  their  standard  methods  for 
detecting the mec A gene12. The addition of a second set of primers to 
amplify a gene which is always present within Staphylococci  like  nuc, 
gyr A and Coag gene has been a very common method118.
DIRECT IDENTIFICATION OF MRSA IN BLOOD CULTURES
This  uses  molecular  methods  for  direct  detection  of  MRSA  in 
blood  cultures  in  order  to  facilitate  rapid  diagnosis  of  MRSA  and 
enables  appropriate  therapeutic  decision  to  be  made  in  a  timely 
manner. Such methods have included gel – based and real time PCR, 
DNA proper and peptide nucleic acid probes27.
DETECTION OF MRSA IN SCREENING SAMPLES
Enrichment  media  are  used to  enhance the  detection  of  MRSA 
by overnight incubation before plating on solid agar. Most of this media 
contain  an  indicator  to  distinguish  S.  aureus,  inhibitory  substance  to 
aid  the  selection  of  S.  aureus from  other  organisms  and  drugs  like 
methicillin, oxacillin or more recently cefoxitin79.
MANAGEMENT OF S. AUREUS INFECTIONS36
 The  antibiotic  used  will  depend  on  the  susceptibility  of  the 
infecting strain.
1) Pencillin susceptible S. aureus – Benzyl Penicillin
Penicillin V and
Amoxicillin can be used
2) Methicillin susceptible S. aureus
 Pencillinase resistant penicillins such as cloxacillin, dicloxacillin, 
flucloxacillin, oxacillin,
 methicillin and naficillin 
 I generation cephalosporins
 penicillin / beta lactamase inhibitors 
  Amoxycillin / clavulanic acid
 Ticarcillin / clavulanic acid
 Ampicillin / Sulbactam
3) Methicillin Resistant S. aureus
- Vancomycin is the drug of choice for serious infections caused 
by S. aureus that are methicillin Resistant
Alternatives - Teicoplanin
Clindamycin
Rifampicin, 
Fluoroquinolones,
Fusidic acid, 
 Co – trimoxazole
4) Vancomycin resistant S. aureus
Quinupristin  –  Dalfopristin  and  Linezolid  are  the  newer 
antimicrobial agents currently available
Daptomycin,  a  novel  bactericidal  agent  that  damages 
cytoplasmic membrane is currently undergoing clinical trials.
PREVENTION OF S. AUREUS INFECTION:
  Falls into three main categories
1) Eradication of S. aureus carriage
2) Hospital infection control measures to prevent nosocomial 
infection, including preoperative antibiotic prophylaxis
3) Vaccination strategies
ERADICATION OF S. AUREUS CARRIAGE
There is considerable evidence to indicate that nasal carriage of 
S. aureus and the development of Staphylococcal infection are related. 
Rates of infection are higher in carrier than in non carriers including the 
development of post- operative wound infections92.
Topical antibiotics such as 2% Mupriocin applied to the nose or 
to exit sites of prosthetic devices is effective. Topical Lysostaphin has 
been  tried  in  animal  models  in  eradicating  S.  aureus nasal 
colonization92.
HOSPITAL INFECTION CONTROL MEASURES 
Regular  alcohol  based  hand  washing,  preoperative  antibiotic 
prophylaxis is also important in preventing surgical sepsis92.
VACCINATION
   The  most  significant  human  Antistaphylococcal  vaccine 
published to date is a single dose of conjugate vaccine comprising  S. 
aureus type 5 and type 8 capsular polysaccharides conjugated to non 
toxic recombinant Pseudomonas aeruginosa exotoxin A92
Aims of the Study
AIMS OF THE STUDY
1) To detect MRSA strains from patients  with soft tissue infection
2) To  compare  the  phenotypic  and  the  genotypic  identification 
methods in the detection of  MRSA for their  sensitivity,  specificity 
and accuracy.  
3) To compare  the  antimicrobial  susceptibility  pattern  of  MRSA and 
MSSA isolates.
4) To  detect  susceptibility  pattern  of  the  isolates  to  vancomycin  by 
disc diffusion method and E-test.
Materials & 
Methods
MATERIALS AND METHODS
Study period 
This cross sectional study was carried out from January 2007 – 
January 2008.
Place of study 
 Institute of Microbiology, Madras Medical College, Chennai – 03     
ETHICAL CONSIDERATION
Ethical and research clearance was obtained from the Institute of 
Ethical  Committee Government General  Hospital  and Madras Medical 
College,Chennai-3.  Permission to  conduct  the  study was sought  from 
the respective hospital authorities. Informed consent was obtained from 
the patients before enrolment into the study
STATISTICAL ANALYSIS
Statistical  analyses  were  carried  out  using  Statistical  Package 
for Social Sciences (SPSS) and Epi – info softwares.
SAMPLE 
Pus samples were collected from skin and soft  tissue infections 
from  patients  admitted  in  general  surgery  and  allied  specialities  at 
Govt. General Hospital, Chennai.
SAMPLE PROCESSING 
The collected pus samples were subjected to  direct  Gram stain 
and inoculated  onto  nutrient  agar,  blood agar  and Mac  Conkey agar. 
The  plates  are  incubated  at  37oC  and  inspected  after  overnight 
incubation.
S.  aureus was identified by its  colony morphology ,  Gram stain 
and catalase test. 
Further confirmation was done by slide and tube coagulase test, 
growth  on  mannitol  salt  agar  and  DNase  test  by  standard 
microbiological techniques as recommended by CLSI guidelines.
1) SLIDE COAGULASE TEST 
The  colony  is  emulsified  in  a  drop  of  saline  on  a  clean  glass 
slide. A drop of sterile human plasma is added to it  and mixed with a 
loop.  A  positive  test  is  indicated  by  clumping  of  the  organisms  in 
suspension.  If  the  suspension  is  smooth,  the  test  was  reported  as 
negative. With each  test a positive and negative control was put up8.
2)TUBE COAGULASE TEST
The colony is  suspended in  1ml of  1  in  6  diluted sterile  human 
plasma.  The tubes are incubated at 370c and examined at the end of 
1,2and 4 hours. The tube is gently tilted to see the coagulam formation. 
If no coagulam is formed at the end of 4 hours ,the tube is reincubated 
at room temperature for 24 hours8.
3) MANNITOL SALT AGAR 
  The organism is inoculated into mannitol salt agar and incubated 
at 37oC for 24 hours.  S. aureus produces yellow coloured colonies. A 
positive control was put up using S. aureus ATCC 259238.
4) DEOXYRIBONUCLEASE (DNase) TEST
DNase is detected by heavily spot inoculating several colonies of 
the  organism on DNase test  medium.  After  24  hours  of  incubation  at 
37oC,  the  plate  is  flooded  with  3.6%  hydrochloric  acid.  After  few 
minutes,  the  medium  under  and  around  the  inoculum  becomes  clear 
indicating hydrolysis of DNA8.      
DETECTION OF METHICILLIN RESISTANCE 
I) DISC DIFFUSION METHOD
Testing  for  Methicillin  resistance  was  done  by  using  1  µg 
Oxacillin and 30 µg Cefoxitin by Kirby Bauer disc diffusion method and 
incubating  at  35oC  for  24  hours.  The  results  are  interpreted  as  per 
CLSI standards25.
SUSCEPTIBLE INTERMEDIATE RESISTANT
Oxacillin (1 µg) ≥ 13 mm 11-12 mm ≤ 10 mm
Cefoxitin (30 µg) ≥ 22 mm NA ≤ 21 mm
ii) OXACILLIN SCREEN AGAR 
Reactants
Mueller – Hinton agar with 4% Nacl
Oxacillin stock solution
Procedure
Oxacillin  working  solutions  6  µg/ml  is  prepared  and  added  to 
Meuller  –  Hinton  agar  with  4% Nacl  and  poured  into  petridishes  and 
allowed  to  set.  A  young  peptone  water  culture  of  S.  aureus 
corresponding  to  0.5  Mc  Farland  turbidity  standard  is  prepared  and 
spot inoculated on the agar.  The plates are incubated for 24 hours at 
35oC.
Results and interpretation
The appearance of even a single colony on oxacillin screen agar 
indicates oxacillin resistance27.
 III)  DETERMINATION OF MINIMUM INHIBITORY CONCENTRATION 
OF OXACILLIN BY BROTH MICRODILUTION METHOD71:
Diffusion  tests,  widely  used  to  determine  the  susceptibility  of 
organisms isolated from clinical specimens have their limitations. Thus 
when  in  doubt,  the  way  to  a  precise  assessment  is  to  determine  the 
Minimum  Inhibitory  Concentration  (MIC)  of  the  antibiotic  to  the 
organisms.  The  MIC  of  oxacillin  for  S.  aureus was  done  by  broth 
microdilution method.
Principle 
  The Minimum Inhibitory Concentration (MIC) is the least amount 
of  antimicrobial  that  will  inhibit  visible  growth  of  an  organism  after 
overnight  incubation.  The  Minimum Bactericidal  Concentration  (MBC) 
is the amount of agent that will  prevent growth after subculture of  the 
organism to antibiotic free medium.
Procedure
MIC was determined by using Mueller Hinton broth with 2% Nacl 
as  the medium in  a  microtitre  plate.  Serial  dilutions  of  Oxacillin  were 
prepared in distilled water. The concentration of Oxacillin  used were  : 
256,128 ,   64,  32,  16,  8,4,2,1,0.5,0.25,0.125 ug/ml.  A young peptone 
water culture of S. aureus corresponding to concentration of 2x105  /ml 
is used as the inoculum. A quality control strain of  S. aureus was also 
included. The microtitre place was incubated at 35oC for 24 hours.
Results and interpretation
 MIC  is  expressed  as  the  highest  dilution  which  inhibited  the 
growth as judged by the lack of turbidity in the tube. Standard strain of 
known  MIC  run  with  the  test  is  used  as  the  control  to  check  the 
reagents and conditions.
MIC > 2 µg / ml – Methicillin Resistant S. aureus
 ≤ 2 µg/ ml – Methicillin Susceptible S. aureus  
IV.DETERMINATION  OF  mec  A GENE  BY  MULTIPLEX  PCR 
METHOD:
 The  mecA gene  is  highly  conserved  among  Staphylococcal 
species, therefore,presently,detection of this gene by polymerase chain 
reaction  (PCR)  is  considered  as  “gold  standard”  for  detection  of 
methicillin  resistance  in  Staphylococci12.  Molecular  diagnostic  assays 
based  on  the  detection  of  the  mecA gene  encountered  difficulty  in 
discriminating  MRSA  from  methicillin  resistant  coagulase  negative 
Staphylococcus species (MR-CoNS)because the  mecA gene is widely 
distributed in S aureus as well as in MR-CoNS85.
In this study multiplex PCR was used which allows the detection 
of  MRSA  by  using  primers  specific  for  methicillin  resistance  and 
coagulase genes. The coag gene was used to differentiate between  S 
aureus and CoNS,a gene which allows species specific identification of 
S  aureus .In  addition  MRSA  harbours  the  mecA  gene  encoding 
methicillin  resistance,  which  is  absent  in  methicillin  susceptible 
Staphylococci85.
Preparation of cell lysate
   Cell  lysates  of  the isolates were  used as DNA template for  colony 
lysate PCR. Around 5-10 colonies were suspended in 100µl of milli  Q 
water and boiled for 5 minutes .It is then centrifuged at 10,000 rpm for 
10 minutes. The supernatant provided templates for PCR reactions58. 
Primers
         Two sets of primers were used for multiplex PCR. The first pair of 
primers was derived from the region of the mecA.
Forward primer- (5”AAAATCGATGGTAAAGGTTGGC) 1282 to 1303 
Reverse primer - (5”AGTTCTCAGTACCGGATTTGC) 1793 to 1814.
The second pair  of  primers  was  derived  from the  region  of  the 
coag gene.
 Forward primer - (5”CGAGACCAAGATTCAACAAG)
Reverse primer - (5”AAAGAAAACCACTCACATCAGT). 
PCR  Reaction Mixture
Components Final Concentration of 
reagents
Quantity of reagents
Water - 13.3 µl
deoxy  Nucleoside  Tri 
Phosphate (d NTP)
(5mM) 2µl
PCR buffer 10x reaction 
buffer(500Mm, KCL, 100 
mM Tris – HCL, pH-8.3)
2µl
mecA gene
 Forward Primer
Reverse Primer
-
0.25µl
0.25µl
Coag gene
Forward Primer
Reverse Primer
-
0.25µl
0.25µl
TAQ Polymerase 2U 0.66µl
Template - 1µl
                                     Total Volume                                         20µ l
Forty  amplification  cycles  were  performed  with  an  automated 
thermocycler according to the following format:
Intial  denaturation  for  5  min  at  950 c;denaturation  for  30s  at 
940 c;annealing for  30s at  55  0c;and extension for  90s at  720 c.   The 
final  cycle  was  followed  by  an  additional  5  min  at  720 c  to  complete 
partial  polymerizations.  Amplified  products  were  run  using  horizontal 
1.5%agarose gel  electrophoresis.  The gel  was  visualized  using  a  UV 
transilluminator.  The amplified  PCR products  and 100 base pair  DNA 
molecular markers were seen as bright fluorescent bands.
Interpretation
                 A 533 bp corresponds to mec A and 810 bp corresponds to 
coag gene specific oligonucleotides.  
DETECTION OF ANTIMICROBIAL SUSCEPTIBILITY PATTERN
 The sensitivity to common antibiotics was done by Kirby – Bauer 
disc diffusion method as recommended by CLSI.
Test Inoculum – 0.5 Mc Farland lawn culture
Control strains – S. aureus ATCC – 25923
The antibiotics used (discs were procured from Himedia)
ANTIMICROBIAL AGENT 
(µG)
INHIBITION ZONE IN MM
RESISTANT 
≤ INTERMEDIATE
SENSITIVE 
≥
1) Penicillin G 10 units 28 - 29 
2) Ampicillin 10 µg 28 - 29 
3) Cephalexin 30 µg 14 15-17 18 
4) Cefaclor 30 µg 14 15-17 18
5) Cefotaxime 30 µg 14 15-22 23
6) Erythromycin 15 µg 13 14-22 23
7) Chloramphenicol 30 µg 12 13-17 18
8) Gentamicin 10 µg 12 13-14 15
9) Amikacin 30 µg 14 15-16 17
10) Ciprofloxacin 5 µg 15 16-20 21
11) Ofloxacin 5 µg 14 15-17 18
12) Vancomycin 30 µg - - 15
13) Teicoplanin 30 µg 10 11-13 14
14) Rifampicin 5 µg 16 17-19 20
15) Linezolid 30 µg - - 21
Plates were incubated at 37oC for 16 – 18 hours. The diameters 
of the zones of inhibition for various drugs were interpreted according 
to CLSI standards.              
                                                                               
                                                                                  DETERMINATIO
N OF VANCOMYCIN RESISTANCE BY DISC DIFFUSION METHOD
 Testing  for  vancomycin  resistance  was  done  by  using  30  ug 
vancomycin  disc  by  Kirby  Bauer  disc  diffusion  method.  The  zone  of 
inhibition is read after incubation at 370c for 24 hours .The results were 
interpreted as per CLSI standards.           
  
MINIMUM INHIBITORY CONCENTRATION DETERMINATION FOR 
VANCOMYCIN BY E – TEST
E – test is based on a combination of both diffusion and dilution 
tests.  It  is  a  quantitative  technique  for  determining  the  antimicrobial 
sensitivity.
Principle 
It consists of a strip made of an inert material with 8 extensions 
that carry the discs of 4mm, resembling the “tooth of comb”.  Towards 
the  stem of  the  strip,  MIC  reading  scale  in  µg/ml  is  given.  A  defined 
concentration of antibiotic is loaded on each of the disc so as to form a 
gradient when placed on agar plate. The gradient remains stable after 
diffusion and the zone of inhibition takes the form of ellipse.
Procedure
A 0.5 Mc Farland turbidity standard of  S. aureus was inoculated 
as a lawn culture on Mueller Hinton agar with 2% Nacl .E – strips were 
placed on the agar  surface and plates were  incubated at 35oC for 24 
hours.
Results and interpretation 
MIC was read where the ellipse intersects the scale.
MIC of vancomycin ≤ 4 µg/ml – susceptible
8-16 µg/ml – intermediate
≥ 32 µg/ml – Resistant strains

Results
RESULTS
This cross sectional study was carried out during the period Jan 
2007  to  Jan  2008  in  the  Institute  of  Microbiology,  Madras  Medical 
College, Chennai.
Methicillin resistance was determined for a total of 150 S. aureus 
isolates  from  pus  samples  by  oxacillin  and  cefoxitin  disc  diffusion 
method, oxacillin screen agar, MIC – broth micro dilution method, and 
PCR for mec A gene.
Vancomycin resistance was determined by disc diffusion and E –
test method.
The  antimicrobial  susceptibility  pattern  to  various  groups  of 
antibiotics were  also done by Kirby Bauer  disc  diffusion method,  The 
results are as follows:
TABLE 1 
 GENDER DISTRIBUTION OF PATIENTS N = 150
SEX NO. OF PATIENTS PERCENTAGE
Male 107 71.3
Female 43 28.7
Table 1 shows that there is male predominance among the cases .
TABLE 2 
 AGE GROUP DISTRIBUTION OF PATIENTS N = 150
Age No. of patients Percentage
0 – 20 14 9.3
21 – 40 84 56
41 – 60 42 28
> 60 10 6.6
Table – 2 shows that the maximum number of isolates were in the age 
group of 21 – 40 years (56%) followed by 41 – 60 years (28%).
TABLE – 3
DISTRIBUTION OF THE SAMPLE SOURCE N = 150
Speciality No. of cases Percentage
1. Orthopedics 51 34
2. General Surgery 42 28
3. Neuro Surgery 17 11.3
4. Dermatology 30 20
5.Cardiothoracic Vascular Surgery 4 2.7
6. Otorhino layrngology 4 2.7
7. Gastroenterology 2 1.4
Most of the isolates were from orthopedics patients 51 (34%) followed 
by general surgery 42 (28%).
TABLE - 4
RESULTS OF METHICILLIN RESISTANCE IN S.AUREUS AS 
DETERMINED BY OXACILLIN (1UG)DISC DIFFUSION METHOD
Pattern of Resistance No. of cases Percentage
1) Susceptible 65 43.3
2) Intermediate 5 3.3
3) Resistant 80 53.3
53.3%of the strains were found to be resistant, 3.3% were intermediate 
and 43.3% were  susceptible strains.
TABLE - 5 
RESULTS OF METHICILLIN RESISTANCE IN S,AUREUS AS 
DETERMINED BY CEFOXITIN (30µG)  DISC DIFFUSION METHOD 
.N=150
Pattern of Resistance No. of cases Percentage
1) Susceptible 69 46
2) Resistant 81 54
46% of strains were sensitive and 54% were resistant by cefoxitin disc 
method.
TABLE - 6
RESULTS OF METHICILLIN RESISTANCE IN S.AUREUS AS 
DETERMINED BY MIC OF OXACILLIN-MICROBROTH DILUTION 
METHOD   N=150
Pattern of Resistance
 
No. of cases Percentage
Susceptible 69 46
Resistance 81 54
46%  of  strains  were  susceptible  and  54%  were  resistant  by 
microbroth dilution method
TABLE - 7
DISTRIBUTION OF OXACILLIN MIC VALUES AMONG S.AUREUS 
N=150
 MIC µg/ ml No. of cases Percentage
> 256 12 8
128 16 10.7
64 16 10.7
32 14 9.3
16 10 6.6
8 9 6
4 5 3
2 2 1.3
1 2 1.3
0.5 8 5.3
0.25 48 32
0.125 8 5.3
TABLE - 8
PATTERN OF OXACILLIN RESISTANCE AMONG MRSA ISOLATES 
N = 82
Oxacillin 
Resistance 
Pattern
MIC µG/ML No. of cases Percentage
High-level ≥ 32 µg/ml 58 71
Moderate level ≤ 16 ≥ 8 µg/ml 19 23
Low level 4 µg/ml 5 6
Among MRSA strains  ,high  level  oxacillin  resistance ≥32 µg/ml 
were found in 58 strains (39%). Moderate level resistance ≤ 16 ≥ 8 µg/
ml were found in 19 strains (13%). Low level resistance 4 µg/ml were 
found in 5 strains (3%).
TABLE - 9
RESULTS OF METHICILLIN RESISTANCE IN S.AUREUS AS 
DETERMINED BY OXACILLIN SCREEN AGAR (6 µG/ML – 
OXACILLIN).
Growth on Oxacillin 
Screen Agar
No. of 
cases
Percentage
Present 81 54
Absent 69 46
54% of  strains  of  S  aureus  were  methicillin  resistant  and  46% 
were susceptible as detected by oxacillin screen agar method.
TABLE 10
RESULTS OF COAG GENE DETECTION BY PCR   N=50
      Coag gene Total no of cases Percentage
      Positive          50         100
      Negative         --           _
The coag gene fragment was observed in all strains.
TABLE- 11
RESULTS OF MEC A GENE DETECTION BY PCR  N =50.
mec A Total no. of cases Percentage
Positive 29 58
Negative 21 42
MRSA  strains  were  unequivocally  detected  within  three  hours 
using  multiplex  PCR  with  coag and  mec  A gene  specific 
oligonucleotides. For MRSA strains ,two discrete DNA fragments,a 533 
base  pair(bp)  mec  A and  810  base  pair(bp)  coag specific  products 
were obtained. .Multiplex PCR detected 29 strains (58%) as methicillin 
resistant and  21 strains (42%) as methicillin susceptible.
TABLE-  12
COMPARISON OF RESULTS OF PHENOTYPIC AND GENOTYPIC 
METHODS IN THE DETECTION OF MRSA   N = 50
Oxacillin disc 
diffusion 
method
Cefoxitin 
disc 
diffusion 
method
Oxacillin 
screen 
agar
MIC by 
Micro 
broth 
dilution 
method
mec A 
gene 
analysis
S I R S R S R S R Pos Neg
24 1 25 24 26 24 26 24 26  29 21
TABLE -13
Cefoxitin disc 
diffusion / oxacillin 
screen agar / 
microbroth dilution
Polymerase Chain 
Reaction  mecA
Positive         Negative
Total
Positive 26 0 26
Negative 3 21 24
Total 29 21 50
Sensitivity - 90%
Specificity - 100%
Positive Predictive value - 100%
Negative Predictive value - 88%
Percentage of false Positives - 0% 
Percentage of false Negatives - 10%
Kappa - 0.88
Accuracy - 94%
TABLE – 14
 ANTI MICROBIAL SUSCEPTIBILITY PATTERN OF MRSA N = 81
Antibiotics
Susceptible
(%)
Intermediate
(%)
Resistant 
(%)
Penicillin 100
Cefotaxime 4 96
Cephalexin 6 94
Ampicillin 8 92
Gentamicin 16.4 3.6 80
Erythromycin 10.5 9.5 80
Cefaclor 22 78
Ciprofloxacin 11 12 77
Co – trimoxazole 36 64
Amikacin 30.5 25.6 44
Ofloxacin 49 11 40
Chloramphenicol 78.1 7.3 14.6
Rifampicin 85.4 7.3 7.3
Vancomycin 100
Teicoplanin 100
Linezolid 100
Among  MRSA  strains  all  strains  (100%)   were  resistant  to 
penicillin.  More  than  80%  strains  were  resistant  to  Cefotaxime, 
cephalexin, cefaclor ampicillin,gentamicin,erythromycin. Moderate level 
of  resistance  was   detected  in  ciprofloxacin,co-trimoxazole,amikacin 
and  ofloxacin.  However  the  strains  were  highly  sensitive  to 
chloramphenicol  and   rifampicin.  100%  sensitivity  were  observed  to 
vancomycin, teicoplanin  and linezold.   
TABLE – 15
ANTI MICROBIAL SUSCEPTIBILITY PATTERN OF MSSA n = 69
Antibiotics
Sensitive
(%)
Intermediate
(%)
Resistant
(%)
Penicillin 4.4 95.6
Ampicillin 22 78
Cephalexin 38 62
Cefotaxime 75 25
Cefaclor 71 29
Erythromycin 52.4 17.6 31
Chloramphenicol 92.6 8.8
Co – trimoxazole 46 54
Gentamicin 57.3 4.4 39.7
Amikacin 60.2 22 17.6
Ciprofloxacin 53 17.6 30.8
Ofloxacin 59.7 13.2 28.5
Vancomycin 100
Teicoplanin 100
Linezolid 100
Rifampicin 98 2
95.6%strains  were  resistant  to  penicillin.  Moderate  level  of 
resistance  were  seen  to  ampicillin,co-trimoxazole  and  cephalexin. 
However majority of strains were sensitive tocefotaxime, erythromycin, 
chloramphenicol ciprofloxacin, ofloxacin and rifampicin. All strains were 
sensitive to vancomycin,teicoplanin and linezolid.
TABLE - 16
RESULTS OF VANCOMYCIN RESISTANCE DETERMINED BY DISC 
DIFFUSION AND  E TEST METHOD   N = 150.
Pattern of resistance No. Of cases Percentage
Susceptible 150 100’
Intermediate - -
Resistant - -
     All strains were sensitive to vancomycin by disc diffusion and E-test 
method.
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FIGURE – 4
RESULTS OF METHICILLIN RESISTANCE IN S.AUREUS AS DETERMINED BY OXACILLIN (1ug) 
DISC DIFFUSION METHOD
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FIGURE – 5
RESULTS OF METHICILLIN RESISTANCE IN S.AUREUS AS DETERMINED BY CEFOXITIN (30ug) 
DISC DIFFUSION METHOD
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FIGURE – 6
RESULTS OF METHICILLIN RESISTANCE IN S.AUREUS AS DETERMINED BY MIC  OF 
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FIGURE – 7
DISTRIBUTION OF OXACILLIN MIC VALUES AMONG S.AUREUS
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Discussion
DISCUSSION
Methicillin  Resistant  Staphylococcus aureus (MRSA)  is  a  major 
nosocomial  pathogen  causing  significant  morbidity  and  mortality.  The 
epidemiology  of  MRSA  has  continued  to  evolve  since  its  first 
appearance  more  than  three  decades  ago.  Epidemic  strains  of  these 
MRSA  are  usually  resistant   to  several  other  antibiotics.  During  the 
past  15  years,  the  appearance  and  world  wide  spread  of  many such 
clones have cuased major  therapeutic  problems in  many hospitals  as 
well  as  diversion  of  considerable  resources to  attempts  at  controlling 
their spread.
Hence  this  study  was  done  to  detect  MRSA  isolates  from 
patients  with  soft  tissue  infection  and  to  determine  its  antimicrobial 
susceptibility pattern. 
A total  of 150  S. aureus were isolated from soft tissue infection 
during the study period Jan 2007 to Jan 2008. 
In  the  present  study,  71.3%  of  isolates  were  from  male  and 
28.7%  were  from  females.  (Table-1).In  the  study  conducted  by 
Christian et  al  in  2007,  60% isolates were  from males and 40% were 
from females22
The maximum number  of  isolates in  this  study were  in  the  age 
group of 21 – 40 (56%) followed by 28% in 41 – 60 years age group. 
(Table-2).This  was similar  to  the study conducted by Prakash et  al  in 
2007, where 55% of the isolates were from 21 – 40 years age group81.
In the present study, S. aureus isolates were predominantly from 
orthopedics  department  51  (34%)  followed  by  general  surgery 
department  42  (28%)  .(Table-3).This  was  similar  to  the  study 
conducted  Srinivasan  et  al  in  2006,  where  the  maximum  number  of 
isolates were from orthopedics department (28%) followed by General 
Surgery (26%)97.
Among 150 isolates of S,aureus, 80 strains (53.3%) strains were 
methicillin  resistant , 5 strains (3.3%) were intermediate and 65 strains 
(43.3%)  were  susceptible  as  determined  by  oxacillin  disc  diffusion 
method.(Table-4) denoting that oxacillin disc diffusion was not reliable 
for  the identification of  intermediate strains.In  the study conducted by 
Erics  et  al  in  2008,  42.7%  strains  were  methicillin  resistant  ,  51.6% 
strains  were  susceptible  and  5.6%  strains  were  intermediate  as 
detected by oxacillin disc diffusion method33.
In  the  present  study,  the  results  of  methicillin  resistance  in  S. 
aureus determined  by cefoxitin disc (30 µg) diffusion method showed 
that 46% of strains were susceptible and 54% of strains were resistant.
(Table-5)  Rahbar  et  al  in  2006 detected  32% of  strains as  methicillin 
resistant and 68% of strains as susceptible  by cefoxitin  disc diffusion 
method85. Cefoxitin is a better inducer of mec A gene and disc diffusion 
tests using cefoxitin give clearer end points and are easier to read than 
tests with oxacillin.
The  present  study  reveals  that  using  cefoxitin  is  a  good 
alternative  method  for  oxacillin  disc  diffusion  method  for  detection  of 
MRSA especially in the identification of intermediate resistant strains of 
S. aureus.
The minimum inhibitory concentration of oxacillin as determined 
by microbroth  dilution  method in  the  present   study  demonstrated  81 
(54%)  strains  as  resistant  and  69  (46%)  as  susceptible.(Table-6).  In 
the  study  conducted  by  A.  Chaudhury  et  al  in  2008,   52.8%  of  S. 
aureus  (MIC  ≥  4  µg/ml)  were  resistant  by  microbroth  dilution 
technique21.
High level oxacillin resistance ≥32 µg/ml were seen in 58 strains 
(38.7%). Moderate level oxacillin resistance ≤ 16 ≥ 8 were seen in 19 
strains (12.6%). Low level oxacillin resistance of 4 µg/ml were seen in 
5 strains (3%).(Table-8).
In the present study, 69 strains (46%) and 81 strains (54%) of S. 
aureus were determined to be susceptible and resistant strains by the 
oxacillin  screen  agar  method  respectively.(Table-9).In  the  study 
conducted by  G K Bhat  et  al  in  2007,  33% strains  of  S aureus  were 
methicillin resistant by oxacillin screen agar method11.
 The  conventional  MRSA  detection  assays  are  simple  and 
relatively  cheap  in  detecting  methicillin  resistance.  Accurate 
determination  of  MRSA  by  conventional  methods  are  subjected  to 
variation  in  inoculum size,  incubation  time,  temperature,  pH  and  salt 
concentration.  It  is  in  such  instance  that  detection  of  mec  A gene  is 
useful by molecular methods85.
In the present study, due to high cost, PCR was restricted to 50 
isolates. Multiplex PCR was used to detect the presence of mecA gene 
and  coag gene in 50 isolates.In this study,  mec A gene was detected 
in  29  isolates  (58%)  (table  –  11).  The  coag gene  was  present  in  all 
isolates.  (Table  10).In  the  study  conducted  by  Raalpalli  et  al  2008, 
45.3%  of  strains  were  detected  as  MRSA  by  multiplex  PCR  using 
mecA84. 
In this study on comparing the phenotypic and genotypic results 
of  the  50  isolates  (Table  –  12)  the  phenotypic  methods  such  as 
oxacillin  screen agar,  cefoxitin disc diffusion, MIC- Microbroth dilution 
method  had  sensitivityof  90%  specificity   of  100%  and  accuracy  of 
94%. The phenotypic results are therefore comparable with that of the 
mec A – the gold standard.
In the study conducted by George et al 2001, the oxacillin screen 
agar  had  a  sensitivity  of  99%  and  specificity  of  98.1%  and  the 
microbroth  dilution  had  a  sensitivity  of  99%  and  specificity  of  100% 
when compared with mec A the gold standard39.In the study conducted 
by  Jana  et  al  2005,  the  cefoxitin  disc  diffusion  method  had  100% 
sensitivity  and specificity when compared with that of mec A gene51.
 
In  the  present  study,  the  antimicrobial  susceptibility  pattern  of 
MRSA and MSSA isolates were determined by disc diffusion method.
Among  the  MRSA  isolates,  100% strains  were  resistant  to  penicillin, 
92%  to  ampicillin,  94%  to  cephalexin,  95.8%  to  cefotaxime,  80%  to 
erythromycin,  80%  to  gentamicin,  77%  to  ciprofloxacin  and  84%  to 
rifampicin.  Moderate  level  of  resistance  was  seen  to  co-trimoxazole 
(64%), Amikacin (44%) and ofloxacin (40%). However all MRSA strains 
were sensitive to vancomycin, teicoplanin and linezolid.
In the study conducted by Anupurba et al 2003, more than 80% 
of MRSA were found to be resistant to majority of antibiotics tested like 
cephalexin,  ciprofloxacin,  penicillin,  co  –  trimoxazole,  gentamicin, 
erythromycin and tetracycline and 60.5% to amikacin. No strains were 
resistant to vancomycin.
Among  the  MSSA  isolates,  95.6%  strains  were  resistant  to 
penicillin,  88%  to  ampicillin,  62%  to  cephalexin,  25%  to  cefotaxime, 
31% to erythromycin,  39.7% to gentamicin  17.6% to Amikacin,  30.8% 
to  ciprofloxacin  and  48.5%  to  ofloxacin.  All  these  isolates  were 
sensitive  to  vancomycin,  teicoplanin  and  linezolid.  In  the  study 
conducted  by  S.  Vidhani  et  al  2001,among  the  MSSA  isolates 
94.5%were  resistant  to  penicillin,89%to  amoxycillin’  32%to  amikacin 
and  22%to  erthyromycin  and  cefotaxime,All  the  MSSA  isolates  were 
sensitive to vancomycin108.
In  the  present  study  ,the  antibiotic  sensitivity  results  show that 
all  MRSA isolates  were  more  resistant  to  antibiotics  as  compared  to 
MSSA isolates which was similar to the study conducted by Vidhani et 
al 2001108.
In the present study, all strains (150) of S. aureus were sensitive 
to  vancomycin  by the disk diffusion method  which was similar  to  the 
study conducted by Rajadurai Pandi et al in 2006 83.E-test detected all 
isolates of  S aureus in  the present study as vancomycin  sensitive.  In 
the  study  conducted  by  Hakim  et  al  2007,13%of  the  isolates  were 
detected as VISA by E –test method.                       .
                               

Summary & 
Conclusion
SUMMARY
1) Among 150 S. aureus isolated form pus samples, maximum number 
of cases were in the age group (21 – 40 years)
2) There was a male preponderance among the isolates. (71.3%)
3) Majority  of  samples  were  from  orthopedics  department  (34%) 
followed by general surgery (28%)
4) Oxacillin disc diffusion method detected 53.3% strains as methicillin 
resistant, 3.3% as intermediate and 43.3% strains as susceptible
5) 54%  of  the  isolates  were  methicillin  resistant  and  46%  were 
susceptible by cefoxitin disc diffusion method.
6) Minimum inhibitory concentration of  oxacillin  by microbroth dilution 
method  showed  that  54%  of  isolates  as  methicillin  resistant  and 
46% of isolates as methicillin susceptible.
7) High  level  of  oxacillin  resistance  were  seen  in  38.7%,  moderate 
level in 12.6% and low level of oxacillin resistance in 3% of isolates.
8) Oxacillin  screen agar  detected  54% strains as  methicillin  resistant 
and 46% strains as susceptible.
9) Multiplex  PCR   detected  58%  strains  as  methicillin  resistant  and 
42% strains as susceptible
10)All  the  isolates  (100%)  were  sensitive  to  vancomycin  by  disc 
diffusion method and E – test.
11) Antibiotic sensitivity  results showed that MRSA strains were  more 
resistant  to  antibiotics  compared  to  methicillin  sensitive 
Staphylococcus aureus (MSSA) isolates.
CONCLUSION
Among  the  Staphylococcus  aureus isolated  from  patients  with 
soft tissue infections, 54% were methicillin resistant. The conventional 
phenotypic  methods  in  the  detection  of  MRSA such  as  cefoxitin  disc 
diffusion  method,  MIC  –  micro  broth  dilution  method  and  oxacillin 
screen  agar  had  a  high  degree  of  sensitivity  and  specificity  when 
compared with that of mec A  - the gold standard and hence it can be 
used  in  the  detection  of  MRSA   isolates.MRSA  isolates  were  more 
resistant  to  many  of  the  antimicrobials  when  compared  with  MSSA 
isolates. All the isolates were sensitive to vancomycin 
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Appendix
APPENDIX 
Nutrient agar - Gms / litre
Peptic digest of animal tissue - 5.00
Beef extract - 1.50
Yeast extract - 1.50
Sodium chloride - 5.00
Agar - 15.00
The above ingredients were suspended in 1 litre of water.  Boild 
to  dissolve  the  medium  completely.  Final  pH  adjusted  to  7.4  ±  0.2. 
Sterilized by autoclaving at 121oC for 15 minutes.
Blood agar 
Sterile defibrinated sheep blood - 10 ml
Nutrient agar (melted) - 100 ml
Sterile nutrient agar was melted, cooled to about 45 – 50oC, 7-10 
ml of sterile defibrinated sheep blood was added, mixed well and 15 ml 
of blood agar was poured in petri dishes.
MacConkey Agar 
Peptone - 2gm
Nacl - 2 gm
Bile salt - 0.5 gm
Lactose - 1 gm
Agar - 1.5 gm
Distilled water - 100 ml
All  the  ingredients  except  lactose  were  dissolved  in  distilled 
water  by heating. pH adjusted to 7.6 1 ml to neutral  red solution was 
added  to  every  100  ml  of  medium  with  lactose  and  sterilized  by 
autoclaving at 121oC for 15 minutes.
Mueller – Hinton Agar
 Beef infusion - 300 ml
Caesin hydrolysate - 17.5 g
Starch - 1.5 g
Agar - 10 g
Distilled water - 1 litre
The  ingredients  were  dissolved  in  one  litre  of  distilled  water, 
mixed  thoroughly.  Heated  with  frequent  agitation  and  boiled  for  1 
minute.  pH  adjusted  to  7.4  ;  Sterilised  by  autoclaving  and  poured  in 
plates.
Mannitol salt agar
Beef extract - 0.1g
Peptone - 1 g
Nacl - 7.5 g
Mannitol - 1g
Agar - 1.5 g
Phenol red - 0.0025
Distilled water - 100 ml
The above ingredients were dissolved in 100ml of distilled water, 
mixed  thoroughly.  Heated  with  frequent  agitation  and  pH  adjusted  to 
7.6. Sterilized by autoclaving and poured in plates.
Oxacillin screen agar 
1) Mueller Hinton agar - 100gms
2) Nacl – 4%
3) Distilled water – 1000 ml
4) Oxacillin – 6 µg / ml
Mueller Hinton agar was dissolved in 1 litre of distilled water and 
Nacl  –  4  gms/100ml  was  added  to  it.  Mixid  thoroughly.  Sterlised  by 
autoclaving. Cooled to about 45 – 50oC – Oxacillin solution 6 µg/ml is 
added to it and poured in plates.
DNase agar
1) Tryptose - 20g
2) Deoxyribonucleic acid – 2 g
3) Sodium chloride – 5 g
4) Agar Powder – 12 g
All  the  ingredients  were  dissolved  in  one litre  of  distilled  water 
and mixed thoroughly. Sterilized by autoclaving and poured in plates.
Abbreviations
ABBREVIATIONS
MRSA - Methicillin resistant Staphylococcus aureus
TSST - Toxic shock Syndrome toxin 
Agr - Accessory global regulator
Sar - Staphylococcal accessory regulator
PBP - Penicillin Binding protein
SCC - Staphylococcal Cassette Chromosome
fem - factors  essential for methicillin resistance
VISA - Vancomycin  Intermediate Staphylococcus 
aureus.
VRSA - Vancomycin Resistant Staphylococcus 
aureus.
PCR - Polymerase Chain Reaction
bp - base pair
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